We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$19.3B
AUM Growth
+$276M
Cap. Flow
-$864M
Cap. Flow %
-4.48%
Top 10 Hldgs %
44.33%
Holding
252
New
9
Increased
38
Reduced
113
Closed
4

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$89.2M
2
MO icon
Altria Group
MO
+$51.7M
3
PM icon
Philip Morris
PM
+$46.8M
4
AAPL icon
Apple
AAPL
+$46.8M
5
XOM icon
ExxonMobil
XOM
+$30.2M

Sector Composition

Rank Sector Weight
1 Consumer Staples 29.2%
2 Financials 18.48%
3 Energy 15.07%
4 Technology 10.96%
5 Healthcare 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
26
Novo Nordisk
NVO
$228B
$254M 1.32%
9,472,804
-595,354
-6% -$15.1M
GOOG icon
27
Alphabet (Google) Class C
GOOG
$4.11T
$249M 1.29%
4,768,060
-305,860
-6% -$15.6M
BLK icon
28
Blackrock
BLK
$167B
$243M 1.26%
472,535
-39,247
-8% -$19.1M
ABT icon
29
Abbott
ABT
$188B
$232M 1.2%
4,056,620
-258,895
-6% -$14.3M
AXP icon
30
American Express
AXP
$224B
$209M 1.08%
2,100,800
-156,448
-7% -$14.9M
V icon
31
Visa
V
$701B
$207M 1.07%
1,818,327
-135,264
-7% -$14.9M
DIS icon
32
Walt Disney
DIS
$171B
$204M 1.05%
1,893,183
-129,379
-6% -$13.3M
WBA
33
DELISTED
Walgreens Boots Alliance
WBA
$188M 0.97%
2,582,263
-130,862
-5% -$9.22M
EL icon
34
Estee Lauder
EL
$30.4B
$184M 0.95%
1,447,737
-138,373
-9% -$16.6M
PX
35
DELISTED
Praxair Inc
PX
$176M 0.91%
1,139,957
-87,612
-7% -$13M
RTX icon
36
RTX Corp
RTX
$290B
$166M 0.86%
2,061,766
-186,145
-8% -$14.1M
KHC icon
37
Kraft Heinz
KHC
$32.8B
$165M 0.86%
2,125,874
-14,386
-0.7% -$1.13M
MRK icon
38
Merck
MRK
$322B
$164M 0.85%
3,060,076
-59,860
-2% -$3.32M
SPGI icon
39
S&P Global
SPGI
$124B
$164M 0.85%
967,996
-16,721
-2% -$2.73M
COP icon
40
ConocoPhillips
COP
$144B
$155M 0.8%
2,825,900
-178,617
-6% -$9.19M
BUD icon
41
AB InBev
BUD
$164B
$124M 0.64%
1,107,604
-26,939
-2% -$3.17M
ADP icon
42
Automatic Data Processing
ADP
$109B
$122M 0.63%
1,037,821
-40,560
-4% -$4.64M
CP icon
43
Canadian Pacific Kansas City
CP
$81B
$118M 0.61%
3,219,180
-276,475
-8% -$9.63M
NVS icon
44
Novartis
NVS
$302B
$113M 0.59%
1,507,676
-99,639
-6% -$7.52M
UNH icon
45
UnitedHealth
UNH
$382B
$107M 0.55%
484,169
-47,923
-9% -$10.2M
WMT icon
46
Walmart Inc
WMT
$909B
$97.5M 0.51%
2,962,053
-8,943
-0.3% -$274K
ICE icon
47
Intercontinental Exchange
ICE
$87.2B
$95.8M 0.5%
1,358,264
-106,169
-7% -$7.29M
ASML icon
48
ASML
ASML
$596B
$90.6M 0.47%
521,367
-66,868
-11% -$11.8M
TTE icon
49
TotalEnergies
TTE
$193B
$87.8M 0.45%
1,588,055
-94,570
-6% -$5.22M
WFC icon
50
Wells Fargo
WFC
$254B
$85.7M 0.44%
1,412,472
-160,755
-10% -$9.08M

Similar funds

Fayez Sarofim & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Fayez Sarofim & Co held 252 positions worth $19.3B, up 1.5% from $19B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co withdrew a net $864M in Q4 2017, closing 4 positions and reducing 113 holdings. Its most notable exit was Celgene Corp, an estimated $89.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, down from 30% a quarter earlier, followed by Financials and Energy.

Against the trend, Fayez Sarofim & Co opened a new position in Blackstone worth $879K.

  • Fayez Sarofim & Co's largest Q4 2017 buy was Blackstone: 27,466 shares worth $879K.
  • Fayez Sarofim & Co added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $6.63M increase.
  • Fayez Sarofim & Co's biggest Q4 2017 reduction was Altria Group, cutting an estimated $51.7M.
  • Fayez Sarofim & Co fully exited Celgene Corp in Q4 2017, selling an estimated $89.2M.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $19.3B portfolio in Q4 2017.
  • Fayez Sarofim & Co opened 9 new positions and closed 4 in Q4 2017.
  • Fayez Sarofim & Co's portfolio value rose 1.5% quarter-over-quarter to $19.3B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2017, filed 13 Feb 2018.